Press release
Recombinant Hepatitis B Vaccine Market Growth, Share, Trends and Overview 2023-2029
Recombinant hepatitis B vaccine market is expected to grow at a CAGR of 5.6% during the forecast period. The rising incidence of acute and chronic hepatitis B infections across the globe is driving market growth. There is an increased demand for recombinant HBV vaccines 10mcg/ml and 10 mcg/0.5 ml, which provide long-lasting protection against chronic hepatitis B infection. The Hepatitis B vaccine is a preventative vaccine for hepatitis B. It's a shot that's administered to the arm or thigh. It works by causing the body to develop virus immunity.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/recombinant-hepatitis-b-vaccine-market
The increasing prevalence of chronic HBV infections, rising awareness about vaccination programs, and rising demand for preventive vaccines are some factors driving the global recombinant hepatitis B vaccine market. In addition, the vaccine manufacturers have been significantly focusing on the development of novel recombinant hepatitis B vaccines. North America is expected to hold a significant share in the market owing to the rising number of chronic HBV cases in the region. The Latin America recombinant hepatitis B vaccine market is driven by the rising focus on the prevention and treatment of HBV infection in the region. Further, owing to the rising incidence of HBV infections and growing awareness about vaccination programs in the region, Asia Pacific is expected to witness lucrative growth in the global recombinant hepatitis B vaccine market.
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
o By Type
o By Application
Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- Merck & Co., Inc., GlaxoSmithKline plc, and Pfizer Inc., among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Recombinant Hepatitis B Vaccine Market Report by Segment
By Type
10mcg/ml
10mcg/0.5ml
By Application
Newborn/Children
Adult
A full report of Recombinant Hepatitis B Vaccine Market is available at: https://www.omrglobal.com/industry-reports/recombinant-hepatitis-b-vaccine-market
Recombinant Hepatitis B Vaccine Market- Segment by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
Company Profiles
Bharat Biotech International Ltd.
CSL Ltd.
Dynavax Technologies Corp
Emergent BioSolutions Inc.
GlaxoSmithKline PLC
KM Biologics (Meiji Holdings Co., Ltd.)
LG Chem Ltd.
Merck & Co., Inc.
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Serum Institute of India Pvt., Ltd.
Reasons to Buying From us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
Visit more report at
https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/%ec%a7%84%ea%b3%b5-%ed%8f%ac%ec%9e%a5-%ec%8b%9c%ec%9e%a5-%ea%b7%9c%eb%aa%a8-%ec%a0%90%ec%9c%a0%ec%9c%a8-%ec%9d%b8%ec%83%81%ec%a0%81%ec%9d%b8-%ec%82%b0%ec%97%85-%ec%84%b1%ec%9e%a5-%eb%b6%84%ec%84%9d/43737/
https://www.asiatimeskorea.com/press-release/%eb%af%b8%ec%a3%bc-%ec%8b%a0%ea%b2%bd-%ec%9e%90%ea%b7%b9%ea%b8%b0-%ec%8b%9c%ec%9e%a5-%ec%a0%90%ec%9c%a0%ec%9c%a8-%eb%8f%99%ed%96%a5-%ea%b7%9c%eb%aa%a8-%ec%97%b0%ea%b5%ac-%eb%b0%8f-%ec%98%88-2/407621/
https://sportmsr.com/%d8%ad%d8%ac%d9%85-%d8%b3%d9%88%d9%82-%d9%86%d8%b8%d8%a7%d9%85-%d8%a7%d9%84%d8%aa%d8%ad%d9%83%d9%85-%d8%b9%d9%86-%d8%a8%d8%b9%d8%af-valve-%d8%8c-%d8%b3%d9%87%d9%85-%d8%8c-%d8%a7%d8%aa%d8%ac%d8%a7/
https://monblogapple.com/2023/03/22/tendances-du-marche-du-traitement-des-varices-rapport-de-recherche-croissance-opportunites-previsions-2023-2029-2/
https://revistaeconomiasocial.com/2023/03/22/informe-de-analisis-de-crecimiento-del-mercado-de-sistemas-de-comunicacion-de-vehiculo-a-vehiculo-y-descripcion-general-2023-2029/
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Hepatitis B Vaccine Market Growth, Share, Trends and Overview 2023-2029 here
News-ID: 3041667 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Recombinant
Recombinant Peptide Market: A Comprehensive Overview
Recombinant Peptide Market was valued at around USD 5.5 billion in 2023 and is expected to reach approximately USD 14.6 billion by 2033, growing at a compound annual growth rate (CAGR) of about 10.2% over the period 2024-2033.
Recombinant Peptide Market Overview
The recombinant peptide market is experiencing rapid growth as advancements in peptide synthesis and recombinant DNA technologies lower production costs and enhance specificity. These peptides are increasingly integrated into therapeutic…
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
Recombinant Collagen Market Outlook and Investment Analysis
Top companies
Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies
Recombinant Collagen Market: Trends & Investment Analysis
Market Growth: The recombinant collagen…
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
Recombinant Collagen Market Outlook and Investment Analysis
Top companies
Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies
Recombinant Collagen Market: Trends & Investment Analysis
Market Growth: The recombinant collagen…
Global Recombinant Cell Culture Supplements Market Size - By Product Type(Recomb …
Recombinant Cell Culture Supplements Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Recombinant Cell Culture Supplements Market Scope: Unveiling Today's Trends
Recombinant Cell Culture Supplements are specialized products designed to enhance growth and productivity in cells used for research and bioproduction.
The market for these supplements is experiencing substantial growth, driven by the rising demand for biopharmaceuticals and advancements in biotechnology. Increasing investments in research and development activities also contribute to market…
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The next…